お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
959837

動脈閉鎖デバイス:医療機器パイプライン評価 2020年

Arteriotomy Closure Devices - Medical Devices Pipeline Assessment, 2020

出版日: | 発行: GlobalData | ページ情報: 英文 | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.53円
動脈閉鎖デバイス:医療機器パイプライン評価 2020年
出版日: 2020年09月01日
発行: GlobalData
ページ情報: 英文
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、動脈閉鎖デバイス製品に関する包括的な情報、開発のさまざまな段階における製品の比較分析、および進行中の臨床試験に関する情報を提供しています。

目次

第1章 目次

第2章 イントロダクション

  • 動脈閉鎖デバイスの概要

第3章 開発中の製品

  • 動脈閉鎖デバイスのパイプライン製品:開発段階別
  • 動脈閉鎖デバイスのパイプライン製品:セグメント別
  • 動脈切開閉鎖器具のパイプライン製品:地域別
  • 動脈閉鎖デバイスのパイプライン製品:規制経路別
  • 動脈閉鎖デバイスのパイプライン製品:推定承認日別
  • 動脈閉鎖デバイス:継続中の臨床試験

第4章 動脈閉鎖デバイス:開発中のパイプライン製品、企業別

  • 動脈閉鎖デバイス企業:開発段階別のパイプライン製品
  • 動脈閉鎖デバイス:開発段階別のパイプライン製品

第5章 動脈閉鎖デバイス企業と製品概要

  • Aporo Biomedical, Inc. (Inactive)
  • CardioDex Ltd (Inactive)
  • CloSys Corp
  • CPC of America Inc
  • Dextera Surgical Inc
  • Essential Medical Inc
  • Harvard University
  • Mayo Clinic
  • ProMed Inc
  • Rex Medical LP
  • Terumo Interventional Systems
  • University of Rochester
  • Vascular Closure Systems Inc
  • Venock Inc
  • Vivasure Medical Ltd.

第6章 動脈閉鎖デバイス:最近の開発

第7章 付録

  • 調査手法
  • GlobalDataについて
  • お問い合わせ
  • 免責事項
図表

List of Tables

List of Tables

  • Table 1: Arteriotomy Closure Devices - Pipeline Products by Stage of Development
  • Table 2: Arteriotomy Closure Devices - Pipeline Products by Segment
  • Table 3: Arteriotomy Closure Devices - Pipeline Products by Territory
  • Table 4: Arteriotomy

List of Figures

List of Figures

  • Figure 1: Arteriotomy Closure Devices - Pipeline Products by Stage of Development
  • Figure 2: Arteriotomy Closure Devices - Pipeline Products by Segment
  • Figure 3: Arteriotomy Closure Devices - Pipeline Products by Territory
  • Figure 4: Arterio
目次
Product Code: GDME0984EPD

GlobalData's Medical Devices sector report, "Arteriotomy Closure Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Arteriotomy Closure Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Arteriotomy closure devices are used to achieve the hemostasis of an arterial puncture site after an angiography procedure.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Arteriotomy Closure Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Arteriotomy Closure Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Arteriotomy Closure Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Arteriotomy Closure Devices Overview

3 Products under Development

  • 3.1 Arteriotomy Closure Devices - Pipeline Products by Stage of Development
  • 3.2 Arteriotomy Closure Devices - Pipeline Products by Segment
  • 3.3 Arteriotomy Closure Devices - Pipeline Products by Territory
  • 3.4 Arteriotomy Closure Devices - Pipeline Products by Regulatory Path
  • 3.5 Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date
  • 3.6 Arteriotomy Closure Devices - Ongoing Clinical Trials

4 Arteriotomy Closure Devices - Pipeline Products under Development by Companies

  • 4.1 Arteriotomy Closure Devices Companies - Pipeline Products by Stage of Development
  • 4.2 Arteriotomy Closure Devices - Pipeline Products by Stage of Development

5 Arteriotomy Closure Devices Companies and Product Overview

  • 5.1 Aporo Biomedical, Inc. (Inactive) Company Overview
  • 5.2 CardioDex Ltd (Inactive) Company Overview
  • 5.3 CloSys Corp Company Overview
  • 5.4 CPC of America Inc Company Overview
  • 5.5 Dextera Surgical Inc Company Overview
  • 5.6 Essential Medical Inc Company Overview
  • 5.7 Harvard University Company Overview
  • 5.8 Mayo Clinic Company Overview
  • 5.9 ProMed Inc Company Overview
  • 5.10 Rex Medical LP Company Overview
  • 5.11 Terumo Interventional Systems Company Overview
  • 5.12 University of Rochester Company Overview
  • 5.13 Vascular Closure Systems Inc Company Overview
  • 5.14 Venock Inc Company Overview
  • 5.15 Vivasure Medical Ltd. Company Overview

6 Arteriotomy Closure Devices- Recent Developments

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.